Unlocking Brain Health with the World’s Most Advanced Eye-Tracking Technology: VNG, VOG, and NeuroAI

The Eyes: A Direct Window into Brain Function

The brain and eyes are intimately connected through a complex network of neural pathways. Every eye movement—whether voluntary or reflexive—reflects the precise function of critical neurological structures, including the brainstem, cerebellum, and cortical processing centers. By analyzing these movements with precision, we gain unparalleled insight into brain health, function, and even performance optimization.

At Schulke Chiropractic & Wellness Solutions, we utilize the world’s most advanced eye-tracking and neurological assessment tools: Videonystagmography (VNG), Videooculography (VOG), and the cutting-edge NeuroAI platform. These tools—powered by Spryson’s (formerly Neurolign) DX200, DX Falcon, and NOTC devices—offer the most in-depth, objective data available today. If you’re looking for cutting-edge neurological assessment in Carmel, IN, or the greater Indianapolis area, our clinic provides state-of-the-art testing solutions.

What is VNG/VOG?

Videonystagmography (VNG) and Videooculography (VOG) are advanced diagnostic technologies that use high-speed infrared cameras and AI-driven analysis to track eye movements with unmatched accuracy. Unlike traditional neurological exams that rely on subjective observation, VNG and VOG provide objective, quantifiable data on brain function in real time.

These tools are widely known for their role in diagnosing vestibular (balance) disorders, but their capabilities extend far beyond dizziness and vertigo. They are revolutionizing fields such as concussion diagnostics, neurodegeneration detection, athletic performance enhancement, and cognitive function analysis.

Why Eye Movement Analysis is Critical for Brain Health

Every time your eyes move, they activate intricate neurological circuits. Disruptions in these movements can indicate dysfunction in the brainstem, cerebellum, or cortical regions—areas commonly affected by neurological conditions such as:

• Concussions & Traumatic Brain Injury (TBI) – Eye-tracking abnormalities are among the most reliable indicators of mild traumatic brain injury (mTBI), even when traditional scans (MRI/CT) appear normal. Recent studies show that 90% of concussed individuals exhibit measurable deficits in oculomotor function, making this an invaluable tool for objective concussion assessment.
• Neurodegenerative Diseases – Early markers of Parkinson’s disease, Alzheimer’s, and multiple sclerosis can be detected through subtle changes in eye movement patterns. Researchers have found that specific abnormalities in smooth pursuit and saccadic eye movements are strong indicators of cognitive decline, offering potential for early intervention.
• Autonomic Nervous System Disorders (Dysautonomia, POTS, Long-COVID Syndrome) – Pupillometry and oculomotor testing reveal dysfunction in autonomic regulation, providing vital clues to complex neurological conditions. The ability to measure these responses objectively helps guide targeted treatment strategies.
• Athletic Performance Optimization – Elite athletes rely on precision eye-tracking to enhance visual reaction time, decision-making speed, and dynamic balance. Even millisecond improvements in reaction time can mean the difference between winning and losing in competitive sports.

The Science Behind Eye-Tracking Technology

The power of VNG, VOG, and NeuroAI lies in their ability to quantify seven primary types of eye movements:

1. Saccades: Rapid, precise eye movements used for quick shifts in focus.
2. Smooth Pursuit: The ability to track a moving object fluidly.
3. Optokinetic Response: Reflexive eye movements triggered by moving patterns.
4. Vestibulo-Ocular Reflex (VOR): Stabilizes vision during head movements.
5. Pupillometry: Measures changes in pupil size in response to stimuli, reflecting autonomic nervous system function.
6. Fixation Stability: The ability to maintain gaze on a stationary object without involuntary movement.
7. Subjective Visual Vertical (SVV): Assesses the brains ability to determine verticality without visual input. This is important for dizzy and balance patients.

Each of these eye movement types is controlled by distinct neural pathways, meaning abnormalities in any of these functions can pinpoint specific areas of neurological dysfunction.

Integrating Functional Neurology for Precision Rehabilitation

At Schulke Chiropractic & Wellness Solutions, we combine the objective data gathered from VNG, VOG, and NeuroAI with cutting-edge functional neurology to create precise, individualized treatment plans. Our expertise in functional neurology in Carmel, IN, and Indianapolis allows us to go beyond diagnosis and into highly targeted brain-based neurorehabilitation and neuro-visual therapy.

• Customized Neuro-Rehabilitation Programs – Using insights from our advanced eye-tracking assessments, we develop personalized functional neurology interventions to retrain neurological pathways and enhance brain function.
• Neuro-Visual Therapy for Optimal Recovery – Patients with concussions, vestibular dysfunction, or neurodegenerative diseases benefit from specialized neuro-visual rehabilitation programs designed to improve balance, coordination, and cognitive performance.
• Performance-Based Functional Neurology – Athletes seeking to enhance reaction time, spatial awareness, and cognitive processing speed benefit from functional neurology-driven performance training informed by the most precise neurological data available.

Introducing NeuroAI: The Next Evolution in Neurological Assessment

While VNG and VOG provide powerful data, NeuroAI takes neurological analysis to an entirely new level. NeuroAI, powered by AI-driven analytics, integrates findings from the DX200, DX Falcon, and NOTC devices to provide a real-time, data-rich neurological assessment. NOTC stands for Neuro Otolithic Test Center.

Unlike traditional assessments that rely on subjective clinician interpretation, NeuroAI uses AI-driven algorithms to detect micro-abnormalities in eye movement, vestibular response, and autonomic function—patterns that the human eye simply cannot see.

Why This Matters for You

Whether you’re an athlete optimizing performance, a patient struggling with lingering post-concussion symptoms, or someone concerned about cognitive decline, the precision of VNG, VOG, and NeuroAI ensures no detail is overlooked.

• For Patients in Carmel, IN & Indianapolis: Objective data means faster, more accurate diagnoses and tailored treatment plans.
• For Athletes: Microsecond differences in eye-tracking and reaction time can be the key to peak performance.
• For Healthcare Providers: Ditch the guesswork—this is the future of evidence-based neurological care.

Take Control of Your Brain Health Today

If you’re experiencing unexplained dizziness, concussion symptoms, cognitive fog, or are simply looking to optimize your neurological function, don’t settle for outdated testing methods.

Book your NeuroAI-powered VNG/VOG assessment today at our Carmel, IN clinic and gain real answers about your brain health.

References

1. Spryson (formerly Neurolign) – https://www.spryson.com/
2. Research on Eye-Tracking and mTBI – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784748/
3. Concussion and Eye Movement Studies – https://journals.sagepub.com/doi/10.1177/0363546517702867
4. Neurodegenerative Disease and Oculomotor Function – https://www.frontiersin.org/articles/10.3389/fneur.2021.628979/full
5. Stuart, S., Parrington, L., Martini, D. N., Popa, B., Fino, P. C., & King, L. A. (2020). The Measurement of Eye Movements in Mild Traumatic Brain Injury: A Structured Review of an Emerging Area. Frontiers in Sports and Active Living, 2, 5. doi:10.3389/fspor.2020.00005. PMID: 33345164; PMCID: PMC7739790.
6. Carrick, F. R., Pagnacco, G., Oggero, E., & Brock, J. B. (2019). Video Nystagmography to Monitor Treatment in Mild Traumatic Brain Injury: A Case Study. Frontiers in Neurology, 10, 137. doi:10.3389/fneur.2019.00137. PMID: 30873192; PMCID: PMC6413644.
7. Mucha, A., Collins, M. W., Elbin, R. J., Furman, J. M., Troutman-Enseki, C., DeWolf, R. M., Marchetti, G., & Kontos, A. P. (2014). A Brief Vestibular/Ocular Motor Screening (VOMS) Assessment to Evaluate Concussions: Preliminary Findings. The American Journal of Sports Medicine, 42(10), 2479-2486. doi:10.1177/0363546514543775. PMID: 25106780.
8. Howell, D. R., O’Brien, M. J., Raghuram, A., Shah, A. S., & Meehan, W. P. (2018). Near Point of Convergence and Gait Deficits in Adolescents After Sport-Related Concussion. Clinical Journal of Sport Medicine, 28(3), 262-267. doi:10.1097/JSM.0000000000000453. PMID: 28498265.
9. Ventura, R. E., Balcer, L. J., & Galetta, S. L. (2014). The Concussion Toolbox: The Role of Vision in the Assessment of Concussion. Seminars in Neurology, 35(05), 599-606. doi:10.1055/s-0035-1563577. PMID: 26568599.
10. Snegireva, N., Derman, W., Patricios, J., & Welman, K. E. (2018). Eye Tracking Technology in Sports-Related Concussion: A Systematic Review and Meta-Analysis. Physiological Measurement, 39(12), 12TR01. doi:10.1088/1361-6579/aaef74. PMID: 30485206.
11. Lau, B. C., Kontos, A. P., Collins, M. W., Mucha, A., & Lovell, M. R. (2011). Which On-Field Signs/Symptoms Predict Protracted Recovery From Sport-Related Concussion Among High School Football Players? The American Journal of Sports Medicine, 39(11), 2311-2318. doi:10.1177/0363546511410655. PMID: 21712482.
12. Pearce, K. L., Sufrinko, A., Lau, B. C., Henry, L., Collins, M. W., & Kontos, A. P. (2015). Near Point of Convergence After a Sport-Related Concussion: Measurement Reliability and Relationship to Neurocognitive Impairment and Symptoms. The American Journal of Sports Medicine, 43(12), 3055-3061. doi:10.1177/0363546515606430. PMID: 26400912.
13. Hunt, A. W., Mah, K., Reed, N., Engel, L., & Keightley, M. (2016). Oculomotor-Based Vision Assessment in Mild Traumatic Brain Injury: A Systematic Review. Journal of Head Trauma Rehabilitation, 31(4), 252-261. doi:10.1097/HTR.0000000000000174. PMID: 26496465.
14. Johnson, B., Hallett, M., & Slobounov, S. (2015). Follow-up Evaluation of Oculomotor Performance With fMRI in the Subacute Phase of Concussion. Neurology, 85(13), 1163-1166. doi:10.1212/WNL.0000000000001968. PMID: 26311756; PMCID: PMC4585580.
15. Stuart, S., Parrington, L., Martini, D. N., Popa, B., Fino, P. C., & King, L. A. (2019). Validation of a Velocity-Based Algorithm to Quantify Saccades During Walking and Turning in Mild Traumatic Brain Injury and Healthy Controls. Physiological Measurement, 40(4), 044006. doi:10.1088/1361-6579/ab159d. PMID: 30995120; PMCID: PMC6511971.
16. Webb, B., Humphreys, D., & Heath, M. (2018). Oculomotor Executive Dysfunction During the Early and Later Stages of Sport-Related Concussion Recovery. Journal of Neurotrauma, 35(16), 1874-1881. doi:10.1089/neu.2018.5673. PMID: 29661095; PMCID: PMC6082300.
17. Whitney, S. L., & Sparto, P. J. (2019). Eye Movements, Dizziness, and Mild Traumatic Brain Injury (mTBI): A Topical Review of Emerging Evidence and Screening Measures. Journal of Neurologic Physical Therapy, 43(Suppl 2), S31-S36. doi:10.1097/NPT.0000000000000272. PMID: 31021910.